Abstract | BACKGROUND: METHODS: We retrospectively analyzed 731 incident patients with idiopathic PAH or CTEPH who entered the Giessen PH registry during 1993-2019. A risk stratification score based on GGT, AST/ALT ratio, and NLR tertiles was compared with a truncated version of the European Society of Cardiology/European Respiratory Society (ESC/ERS) risk stratification scheme. Associations with survival were evaluated using Kaplan-Meier and Cox regression analyses. External validation was performed in 311 patients with various types of PAH or CTEPH from a second German center. RESULTS: GGT levels, AST/ALT, and NLR independently predicted mortality at baseline and during follow-up. The scoring system based on these biomarkers predicted mortality at baseline and during follow-up (both log-rank p < 0.001; hazard ratio [95% confidence interval], high vs low risk: baseline, 7.6 [3.9, 15.0]; follow-up, 13.3 [4.8, 37.1]). Five-year survival of low, intermediate, and high risk groups was 92%, 76%, and 51%, respectively, at baseline and 95%, 78%, and 50%, respectively, during follow-up. Our scoring system showed characteristics comparable to the ESC/ERS scheme, and predicted mortality in the validation cohort. CONCLUSION: GGT, AST/ALT, and NLR were reliable prognostic biomarkers at baseline and during follow-up, with predictive power comparable to the gold standard for risk stratification.
|
Authors | Athiththan Yogeswaran, Khodr Tello, Jonas Lund, Hans Klose, Lars Harbaum, Natascha Sommer, Tim Oqueka, Jan K Hennigs, Friedrich Grimminger, Werner Seeger, Hossein Ardeschir Ghofrani, Manuel J Richter, Henning Gall |
Journal | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
(J Heart Lung Transplant)
Vol. 41
Issue 3
Pg. 400-410
(03 2022)
ISSN: 1557-3117 [Electronic] United States |
PMID | 34857454
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2021 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved. |
Chemical References |
|
Topics |
- Adult
- Aged
- Biomarkers
(blood)
- Chronic Disease
- Familial Primary Pulmonary Hypertension
(blood, epidemiology)
- Female
- Humans
- Hypertension, Pulmonary
(blood, epidemiology)
- Male
- Middle Aged
- Prognosis
- Pulmonary Embolism
(blood, epidemiology)
- Retrospective Studies
- Risk Assessment
- Survival Rate
|